感染制御市場：感染、製品、エンドユーザー別-2024-2030年の世界予測

感染制御市場規模は2023年に436億2,000万米ドルと推計され、2024年には457億9,000万米ドル、CAGR 5.23％で2030年には623億6,000万米ドルに達すると予測されています。

感染制御は、感染症の蔓延を防止するための規律あるアプローチと実践を指します。この多面的な学問分野には、感染源を特定し、感染症が広がるメカニズムを理解し、感染因子の伝播を緩和するための戦略的対策を実施することが含まれます。医療従事者、患者、そして一般市民を伝染病の危険から守るために、科学、理論、実践が組み合わされています。感染制御市場は、院内感染発生率の上昇、感染症アウトブレイクにおける感染制御に対する認識と需要の高まり、滅菌技術の進歩、ヘルスケアインフラの拡大、感染予防対策に関する世界の厳しい規制などにより、力強い成長を遂げています。市場開拓の機会としては、環境に優しい消毒方法の開発、衛生管理のためのIoTやAIの導入、医療水準が向上している新興国市場への参入、感染性廃棄物処理のための革新的なソリューションなどが挙げられます。とはいえ、高度な滅菌機器の高額なコスト、低所得地域における限られた認識と実践の導入、トレーニング不足による医療従事者の抵抗、感染性廃棄物処理に関する環境問題などの課題が顕著な障壁となっています。持続的な成長を達成するために、この分野では費用対効果の高い滅菌技術、環境に優しい使い捨て製品、自動化されたリアルタイムの感染制御モニタリング、感染制御ソリューションをより身近で手頃なものにするための協力的な取り組みなどの技術革新が求められています。

製品医療機器の安全性を確保するため、芽胞を含むあらゆる形態の微生物を除去する滅菌の利用が急増しています。

このカテゴリーには、表面、器具、皮膚に付着した有害な病原体を除去または減少させるよう設計された製品が含まれます。手指消毒剤は、人の手指に付着した細菌を殺菌または増殖を抑制するよう処方されています。ヘルスケア環境では、二次汚染や感染を防ぐために重要です。器具消毒剤は、医療器具の滅菌・消毒に使用され、感染伝播のリスクを低減します。皮膚消毒剤は、医療処置の前や汚染物質への曝露後に、皮膚から微生物を除去するために使用される消毒剤です。表面消毒剤は、さまざまな環境において表面を消毒するために設計された製品で、感染拡大のリスクを効果的に低減します。消毒プロセスで使用される装置や機械は、効率と効果を高める。フラッシャーディスインフェクターは、医療機器や配管設備の洗浄・消毒を自動化したシステムで、微生物汚染を防止します。超音波洗浄器は、洗浄液に超音波を照射して汚染物質を除去するもので、特にデリケートな器具に効果的です。UV-Cライトを照射し、細菌、ウイルス、真菌の病原体を破壊するUV-Ray殺菌機は、表面、水、空気の殺菌に適しています。ウォッシャーディスインフェクターは、高温で効果的に作動し、医療器具を徹底的に洗浄・消毒します。消毒剤の物理的組成は、さまざまな用途や好みに合わせて調整されます。消毒剤スプレーは、表面や空気中に簡単に塗布できるように設計された液体製剤で、迅速で便利な消毒を提供します。消毒ウェットティッシュは、消毒液を含浸させたウェットティッシュで、表面の迅速な清掃や消毒に最適です。液体消毒剤は、直接塗布することも、希釈して幅広い消毒作業に使用することもできます。消毒方法は、殺微生物活性の程度によって分類され、様々な用途に適した製品を選択する上で重要です。高レベル消毒は、大量の細菌芽胞を除くすべての微生物を破壊します。無菌の身体部位に接触する物品に使用されます。中レベルは、ウイルス、細菌、真菌、マイコバクテリアを不活性化するが、必ずしも大量の細菌芽胞を不活性化するわけではないです。

低レベルは、ほとんどの細菌、一部のウイルス、真菌を除去するが、マイコバクテリアや芽胞菌は死滅させず、重要でない表面に適しています。内視鏡の再処理は、内視鏡の使用に伴う感染を予防するために非常に重要であり、徹底した消毒を行うための特定の手順と製品が必要となります。消耗品には、内視鏡の洗浄および消毒用に特別に設計された洗剤、ワイプ、ブラシが含まれます。保護バリアは、物理的なバリアを提供し、医療従事者や患者を感染源から保護する機器や材料です。カバーおよびクロージャーは、汚染を防ぐために機器やエリアを密閉またはカバーするように設計されています。ゴーグルは、感染性物質を含む可能性のある飛沫、スプレー、飛沫から目を保護します。医療用不織布は、ガウン、ドレープ、マスクなど、二次汚染を防ぐために医療現場で使用される使い捨ての布地です。滅菌は、医療機器の安全性を確保するためにヘルスケア施設で採用されている、芽胞を含むあらゆる形態の微生物生命を除去するプロセスです。電子ビーム滅菌は、電子ビームを利用し、さまざまな素材に適した医療製品を迅速かつ効果的に滅菌します。機器滅菌は、蒸気、乾熱、薬品などの方法で医療機器を滅菌し、安全に再使用できるようにします。ETO滅菌は、エチレンオキサイドガスを用いて医療機器を滅菌するもので、熱や湿気に弱い素材に効果的です。ろ過滅菌は、ろ過膜を通して微生物を物理的に除去するもので、熱に弱い液体に適しています。ガンマ線滅菌は、ガンマ線によって製品を透過し、徹底的に滅菌するもので、一般的に単回使用の医療機器に使用されます。放射線滅菌はガンマ線と電子ビーム滅菌を含み、様々な製品に深く浸透します。蒸気滅菌は、耐熱性機器に理想的な微生物不活性化を達成するために、加圧蒸気を利用した広く使用されている効果的な方法です。

エンドユーザー：病院・クリニック分野における感染制御の利用拡大

飲食品分野では、感染制御は厳格な衛生管理と除菌作業を通じて、食中毒を予防しています。この市場セグメントでは、幅広い病原体に対する効果的なソリューションでありながら、食品加工環境でも安全に使用できるものが求められています。成長機会は、食品安全の規制基準を満たす革新的な消毒技術と環境に優しい除菌剤にあります。ヘルスケア関連感染（HAI）を予防することが極めて重要であるため、ヘルスケアとクリニックは依然として感染制御の最前線にあります。病院や診療所では、滅菌装置、消毒剤、患者ケアのための無菌環境を確保するサービスなど、包括的なソリューションが求められています。技術の進歩と患者の安全基準の重視の高まりが、高効率の製品とサービスへの需要を後押ししています。研究機関やバイオテクノロジー企業を含むライフサイエンス業界では、研究・生産プロセスの完全性を確保するために厳格な対策が必要です。ライフサイエンス業界は、業務にシームレスに統合できる革新的な滅菌・除染技術を求めています。機密性の高い材料や実験結果を損なうことなく、効果的なソリューションを提供することに重点を置いています。医療機器企業にとって、感染制御は医療製品の設計、製造、使用において極めて重要です。ここでは、特に侵襲的な処置に関わる機器の微生物汚染を防ぐ滅菌プロセスやコーティングが求められています。特定の機器要件に合わせたカスタムソリューションを提供できる感染制御のスペシャリストとの提携は、戦略的な機会となります。製薬会社は、製品やクリーンルーム環境の無菌性を確保するために感染制御を必要としています。製薬会社は、無菌状態を維持し、製造中の二次汚染を防ぐ技術やサービスに関心を持っています。これらの企業は世界に事業を展開することが多いため、国際規格への準拠や拡張性のあるソリューションへの需要が高まっています。

地域別の洞察

南北アメリカは、CDCやFDAなどの厳しい規制ガイドラインに後押しされ、先進的な感染制御テクノロジーの採用率が高いです。この地域には感染制御市場に参入している企業が数社あり、世界な生産能力に大きく貢献しています。さらに、研究と技術革新に重点が置かれており、感染制御の手法の継続的な進歩を可能にしています。逆に、APAC地域はこの分野で最も急成長しています。これは、特に中国やインドなどの国々で、健康と衛生習慣に対する意識の高まり、医療費の増加、医療インフラの拡大が見られるためです。同地域の生産状況は、国内企業と国際企業が混在しており、需要の拡大に対応するために製造能力の拡大に努めています。EMEA地域は多様な様相を呈しており、欧州諸国では、ヘルスケア規制と高品質基準に後押しされ、感染制御の慣行が確立されています。中東・アフリカ地域は、徐々に改善されつつあるもの、ヘルスケア施設やテクノロジーへのアクセスの不均衡に関連する課題に直面しています。この地域には、十分なサービスを受けていない地域への進出を目指す国内外の企業が混在しており、感染制御の実践における成長の可能性を示しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは感染制御市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、感染制御市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.感染制御市場の市場規模および予測は？

2.感染制御市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.感染制御市場の技術動向と規制枠組みは？

4.感染制御市場における主要ベンダーの市場シェアは？

5.感染制御市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 院内感染の発生率上昇と感染制御製品の使用急増
    • 外科手術の増加と適切な安全対策の必要性
    • 医療機器・製薬業界における感染制御製品の採用急増
  • 抑制要因
    • 化学系消毒剤に伴う副作用
  • 機会
    • 病院や診療所による滅菌サービスのアウトソーシングの増加
    • 感染制御製品の製造におけるメーカーの投資増加
  • 課題
    • 感染制御の代替製品および技術の可用性
• 市場セグメンテーション分析
  • 製品：滅菌の使用が急増し、胞子を含むあらゆる形態の微生物を除去して医療機器の安全性を確保しています。
  • エンドユーザー：病院・診療所部門における感染制御の使用法の進化
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 感染制御市場トランスミッション

• 空中
• ブラッドボーン
• 契約

第7章 感染制御市場：製品別

• 清掃と消毒
• 内視鏡の再処理
• 防護バリア
• 殺菌

第8章 感染制御市場：エンドユーザー別

• 飲食品会社
• 病院・クリニック
• ライフサイエンス産業
• 医療機器企業
• 製薬会社

第9章 南北アメリカの感染制御市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の感染制御市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの感染制御市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • フロイデンベルグメディカル、コスタリカに第2の生産施設を設立
  • WPT Nonwovens、ケンタッキー州の製造施設に1,950万米ドルを投資し、地域経済を活性化
  • Berryは、感染制御プロトコルで義務付けられている厳格な安全性と衛生基準を満たす軽量チューブ閉鎖ソリューションを発売しました。
• 戦略分析と提言

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. INFECTION CONTROL MARKET RESEARCH PROCESS
• FIGURE 2. INFECTION CONTROL MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. INFECTION CONTROL MARKET DYNAMICS
• FIGURE 7. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INFECTION CONTROL MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL INFECTION CONTROL MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL INFECTION CONTROL MARKET SIZE, BY AIRBORNE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL INFECTION CONTROL MARKET SIZE, BY AIRBORNE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL INFECTION CONTROL MARKET SIZE, BY BLOODBORNE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL INFECTION CONTROL MARKET SIZE, BY BLOODBORNE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONTRACT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONTRACT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL INFECTION CONTROL MARKET SIZE, BY HAND DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL INFECTION CONTROL MARKET SIZE, BY HAND DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL INFECTION CONTROL MARKET SIZE, BY INSTRUMENT DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL INFECTION CONTROL MARKET SIZE, BY INSTRUMENT DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL INFECTION CONTROL MARKET SIZE, BY SKIN DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL INFECTION CONTROL MARKET SIZE, BY SKIN DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL INFECTION CONTROL MARKET SIZE, BY SURFACE DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL INFECTION CONTROL MARKET SIZE, BY SURFACE DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL INFECTION CONTROL MARKET SIZE, BY FLUSHER DISINFECTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL INFECTION CONTROL MARKET SIZE, BY FLUSHER DISINFECTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL INFECTION CONTROL MARKET SIZE, BY ULTRASONIC CLEANERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL INFECTION CONTROL MARKET SIZE, BY ULTRASONIC CLEANERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL INFECTION CONTROL MARKET SIZE, BY UV-RAY DISINFECTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL INFECTION CONTROL MARKET SIZE, BY UV-RAY DISINFECTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL INFECTION CONTROL MARKET SIZE, BY WASHER DISINFECTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL INFECTION CONTROL MARKET SIZE, BY WASHER DISINFECTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT SPRAYS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT SPRAYS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT WIPES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT WIPES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIQUID DISINFECTANTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIQUID DISINFECTANTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL INFECTION CONTROL MARKET SIZE, BY HIGH-LEVEL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL INFECTION CONTROL MARKET SIZE, BY HIGH-LEVEL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL INFECTION CONTROL MARKET SIZE, BY INTERMEDIATE-LEVEL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL INFECTION CONTROL MARKET SIZE, BY INTERMEDIATE-LEVEL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL INFECTION CONTROL MARKET SIZE, BY LOW-LEVEL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL INFECTION CONTROL MARKET SIZE, BY LOW-LEVEL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 67. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
• TABLE 68. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
• TABLE 69. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 70. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 71. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 72. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 73. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 74. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 75. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
• TABLE 76. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
• TABLE 77. GLOBAL INFECTION CONTROL MARKET SIZE, BY COVERS & CLOSURES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 78. GLOBAL INFECTION CONTROL MARKET SIZE, BY COVERS & CLOSURES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 79. GLOBAL INFECTION CONTROL MARKET SIZE, BY GOGGLES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 80. GLOBAL INFECTION CONTROL MARKET SIZE, BY GOGGLES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 81. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL NONWOVENS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 82. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL NONWOVENS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 83. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 84. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 85. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
• TABLE 86. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
• TABLE 87. GLOBAL INFECTION CONTROL MARKET SIZE, BY E-BEAM STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 88. GLOBAL INFECTION CONTROL MARKET SIZE, BY E-BEAM STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 89. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 90. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 91. GLOBAL INFECTION CONTROL MARKET SIZE, BY ETO STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 92. GLOBAL INFECTION CONTROL MARKET SIZE, BY ETO STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 93. GLOBAL INFECTION CONTROL MARKET SIZE, BY FILTRATION STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 94. GLOBAL INFECTION CONTROL MARKET SIZE, BY FILTRATION STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 95. GLOBAL INFECTION CONTROL MARKET SIZE, BY GAMMA STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 96. GLOBAL INFECTION CONTROL MARKET SIZE, BY GAMMA STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 97. GLOBAL INFECTION CONTROL MARKET SIZE, BY RADIATION STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 98. GLOBAL INFECTION CONTROL MARKET SIZE, BY RADIATION STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 99. GLOBAL INFECTION CONTROL MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 100. GLOBAL INFECTION CONTROL MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 101. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 102. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 103. GLOBAL INFECTION CONTROL MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 104. GLOBAL INFECTION CONTROL MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 105. GLOBAL INFECTION CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 106. GLOBAL INFECTION CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 107. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIFE SCIENCES INDUSTRY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 108. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIFE SCIENCES INDUSTRY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 109. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 110. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 111. GLOBAL INFECTION CONTROL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 112. GLOBAL INFECTION CONTROL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 113. AMERICAS INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
• TABLE 114. AMERICAS INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
• TABLE 115. AMERICAS INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 116. AMERICAS INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 117. AMERICAS INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 118. AMERICAS INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 119. AMERICAS INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
• TABLE 120. AMERICAS INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
• TABLE 121. AMERICAS INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 122. AMERICAS INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 123. AMERICAS INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 124. AMERICAS INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 125. AMERICAS INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 126. AMERICAS INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 127. AMERICAS INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
• TABLE 128. AMERICAS INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
• TABLE 129. AMERICAS INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
• TABLE 130. AMERICAS INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
• TABLE 131. AMERICAS INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
• TABLE 132. AMERICAS INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
• TABLE 133. AMERICAS INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 134. AMERICAS INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 135. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 136. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 137. ARGENTINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
• TABLE 138. ARGENTINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
• TABLE 139. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 140. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 141. ARGENTINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 142. ARGENTINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 143. ARGENTINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
• TABLE 144. ARGENTINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
• TABLE 145. ARGENTINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 146. ARGENTINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 147. ARGENTINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 148. ARGENTINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 149. ARGENTINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 150. ARGENTINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 151. ARGENTINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
• TABLE 152. ARGENTINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
• TABLE 153. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
• TABLE 154. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
• TABLE 155. ARGENTINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
• TABLE 156. ARGENTINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
• TABLE 157. ARGENTINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 158. ARGENTINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 159. BRAZIL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
• TABLE 160. BRAZIL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
• TABLE 161. BRAZIL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 162. BRAZIL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 163. BRAZIL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 164. BRAZIL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 165. BRAZIL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
• TABLE 166. BRAZIL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
• TABLE 167. BRAZIL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 168. BRAZIL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 169. BRAZIL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 170. BRAZIL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 171. BRAZIL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 172. BRAZIL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 173. BRAZIL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
• TABLE 174. BRAZIL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
• TABLE 175. BRAZIL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
• TABLE 176. BRAZIL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
• TABLE 177. BRAZIL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
• TABLE 178. BRAZIL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
• TABLE 179. BRAZIL INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 180. BRAZIL INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 181. CANADA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
• TABLE 182. CANADA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
• TABLE 183. CANADA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 184. CANADA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 185. CANADA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 186. CANADA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 187. CANADA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
• TABLE 188. CANADA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
• TABLE 189. CANADA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 190. CANADA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 191. CANADA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 192. CANADA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 193. CANADA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 194. CANADA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 195. CANADA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
• TABLE 196. CANADA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
• TABLE 197. CANADA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
• TABLE 198. CANADA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
• TABLE 199. CANADA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
• TABLE 200. CANADA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
• TABLE 201. CANADA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 202. CANADA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 203. MEXICO INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
• TABLE 204. MEXICO INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
• TABLE 205. MEXICO INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 206. MEXICO INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 207. MEXICO INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 208. MEXICO INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 209. MEXICO INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
• TABLE 210. MEXICO INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
• TABLE 211. MEXICO INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 212. MEXICO INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 213. MEXICO INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 214. MEXICO INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 215. MEXICO INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 216. MEXICO INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 217. MEXICO INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
• TABLE 218. MEXICO INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
• TABLE 219. MEXICO INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
• TABLE 220. MEXICO INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
• TABLE 221. MEXICO INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
• TABLE 222. MEXICO INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
• TABLE 223. MEXICO INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 224. MEXICO INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 225. UNITED STATES INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
• TABLE 226. UNITED STATES INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
• TABLE 227. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 228. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 229. UNITED STATES INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 230. UNITED STATES INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 231. UNITED STATES INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
• TABLE 232. UNITED STATES INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
• TABLE 233. UNITED STATES INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 234. UNITED STATES INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 235. UNITED STATES INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 236. UNITED STATES INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 237. UNITED STATES INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 238. UNITED STATES INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 239. UNITED STATES INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
• TABLE 240. UNITED STATES INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
• TABLE 241. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
• TABLE 242. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
• TABLE 243. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
• TABLE 244. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
• TABLE 245. UNITED STATES INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 246. UNITED STATES INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 247. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 248. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 249. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
• TABLE 250. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
• TABLE 251. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 252. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 253. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 254. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 255. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
• TABLE 256. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
• TABLE 257. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 258. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 259. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 260. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 261. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 262. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 263. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
• TABLE 264. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
• TABLE 265. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
• TABLE 266. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
• TABLE 267. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
• TABLE 268. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
• TABLE 269. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 270. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 271. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 272. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 273. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
• TABLE 274. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
• TABLE 275. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 276. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 277. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 278. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 279. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
• TABLE 280. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
• TABLE 281. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 282. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 283. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 284. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 285. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 286. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 287. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
• TABLE 288. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
• TABLE 289. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
• TABLE 290. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
• TABLE 291. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
• TABLE 292. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
• TABLE 293. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 294. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 295. CHINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
• TABLE 296. CHINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
• TABLE 297. CHINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 298. CHINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 299. CHINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 300. CHINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 301. CHINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
• TABLE 302. CHINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
• TABLE 303. CHINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 304. CHINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 305. CHINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 306. CHINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 307. CHINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 308. CHINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 309. CHINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
• TABLE 310. CHINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
• TABLE 311. CHINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
• TABLE 312. CHINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
• TABLE 313. CHINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
• TABLE 314. CHINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
• TABLE 315. CHINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 316. CHINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 317. INDIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
• TABLE 318. INDIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MILLION)
• TABLE 319. INDIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2023 (USD MILLION)
• TABLE 320. INDIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2024-2030 (USD MILLION)
• TABLE 321. INDIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 322. INDIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 323. INDIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2023 (USD MILLION)
• TABLE 324. INDIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2024-2030 (USD MILLION)
• TABLE 325. INDIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 326. INDIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 327. INDIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
• TABLE 328. INDIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
• TABLE 329. INDIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2023 (USD MILLION)
• TABLE 330. INDIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2024-2030 (USD MILLION)
• TABLE 331. INDIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2023 (USD MILLION)
• TABLE 332. INDIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2024-2030 (USD MILLION)
• TABLE 333. INDIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2023 (USD MILLION)
• TABLE 334. INDIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2024-2030 (USD MILLION)
• TABLE 335. INDIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2023 (USD MILLION)
• TABLE 336. INDIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2024-2030 (USD MILLION)
• TABLE 337. INDIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 338. INDIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 339. INDONESIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2023 (USD MILLION)
• TABLE 340. INDONESIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2024-2030 (USD MIL

[195 Pages Report] The Infection Control Market size was estimated at USD 43.62 billion in 2023 and expected to reach USD 45.79 billion in 2024, at a CAGR 5.23% to reach USD 62.36 billion by 2030.

Infection control refers to the disciplined approach and practices designed to prevent the spreading of infectious diseases. This multifaceted discipline encompasses identifying sources of infections, understanding the mechanisms through which infections spread, and implementing strategic measures to mitigate the transmission of infectious agents. It involves a combination of science, theory, and practices to protect healthcare providers, patients, and the public from the dangers of contagious diseases. The infection control market is experiencing robust growth, driven by the rise of hospital-acquired infection incidence, heightened awareness and demand for infection control amidst infectious disease outbreaks, advancements in sterilization technologies, expanding healthcare infrastructure, and stringent global regulations on infection prevention practices. Opportunities for market expansion include the development of eco-friendly disinfection methods, implementation of IoT and AI for hygiene management, entry into emerging markets with rising healthcare standards, and innovative solutions for the disposal of infectious waste. Nonetheless, challenges such as the high costs of advanced sterilization equipment, limited awareness and practice adoption in lower-income regions, healthcare worker resistance due to training deficiencies, and environmental concerns over infectious waste disposal are notable barriers. To achieve sustained growth, the sector is poised for innovation in cost-effective sterilization technologies, eco-friendly disposable products, automated and real-time infection control monitoring, and collaborative efforts to make infection control solutions more accessible and affordable worldwide.

Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices

Cleaning & disinfection are essential in preventing the spread of infection, this category includes products designed to eliminate or reduce harmful pathogens on surfaces, instruments, and skin. Hand Disinfectants are formulated to kill or inhibit the growth of germs on human hands. These are crucial in healthcare settings to prevent cross-contamination and infections. Instrument disinfectants are used for sterilizing and disinfecting medical instruments, reducing the risk of infection transmission. Skin disinfectants are antiseptic agents used to cleanse the skin of microbes before medical procedures or after exposure to contaminants. Surface disinfectants are products designed to sanitize surfaces in various environments, effectively reducing the risk of spreading infections. Devices and machines used in the disinfection process enhance efficiency and effectiveness. Flusher disinfectors are automated systems for the cleaning and Disinfection of medical devices and plumbing fixtures to prevent microbial contamination. Ultrasonic cleaners use ultrasonic waves in a cleaning solution to remove contaminants from items, which is particularly effective for delicate instruments. UV-Ray disinfectors that deploy UV-C light to destroy bacterial, viral, and fungal pathogens suitable for surface, water, and air disinfection. Washer disinfectors thoroughly clean and disinfect medical utensils, operating effectively at high temperatures. The physical composition of disinfection agents is tailored for various uses and preferences. Disinfectant sprays are liquid formulations designed for easy application on surfaces or air, offering quick and convenient Disinfection. Disinfectant wipes are pre-moistened towelettes impregnated with disinfectant solutions, ideal for quick cleanup and Disinfection of surfaces. Liquid disinfectants can be applied directly or diluted used for a broad range of disinfection tasks. Disinfection practices are categorized by the extent of microbicidal activity, which is important in selecting the appropriate products for various applications. High-Level Disinfection destroys all microorganisms, except large numbers of bacterial spores. Used for items that come in contact with sterile body areas. Intermediate-level inactivates viruses, bacteria, fungi, and mycobacteria, but not necessarily high numbers of bacterial spores.

Low-level eliminates most bacteria, some viruses, and fungi but does not kill mycobacteria or spores and is suitable for non-critical surfaces. Endoscope reprocessing is critical for preventing infections associated with endoscope use, involving specific steps and products to ensure thorough Disinfection. Consumables include detergents, wipes, and brushes specifically designed for cleaning and disinfecting endoscopes. Protective Barriers are quipment and materials that provide a physical barrier, protecting healthcare workers and patients from infectious agents. Covers & closures are designed to seal or cover equipment and areas to prevent contamination. Goggles protect eyes from splashes, sprays, and droplets that may contain infectious agents. Medical nonwovens are disposable fabrics used in medical settings to prevent cross-contamination, including gowns, drapes, and masks. Sterilization is the process that eliminates all forms of microbial life, including spores, employed in healthcare facilities to ensure the safety of medical devices. E-Beam sterilization utilizes electron beams to sterilize medical products quickly and effectively, suitable for various materials. Equipment sterilization involves methods such as steam, dry heat, and chemicals to sterilize medical equipment, ensuring its safe reuse. ETO sterilization uses ethylene oxide gas to sterilize medical devices, effective for materials sensitive to heat and moisture. Filtration sterilization employs physical removal of microorganisms through a filtration membrane, suitable for heat-sensitive liquids. Gamma sterilization relies on gamma rays to penetrate and sterilize products thoroughly, commonly used for single-use medical devices. Radiation sterilization encompasses gamma and e-beam sterilization, offering deep penetration for various products. Steam sterilization is a widely used, effective method utilizing pressurized steam to achieve microbial inactivation, ideal for heat-resistant devices.

End-User: Evolving usage of infection control in hospitals & clinics sector

In the food and beverage sector, infection control prevents foodborne illnesses through stringent hygiene and sanitization practices. This market segment demands effective solutions against a broad spectrum of pathogens yet safe for use in food processing environments. Growth opportunities lie in innovative disinfection technologies and eco-friendly sanitizers that meet regulatory standards for food safety. Hospitals and clinics remain at the forefront of infection control due to the critical need to prevent healthcare-associated infections (HAIs). Hospitals and clinics require comprehensive solutions, including sterilization equipment, disinfectants, and services that ensure a sterile environment for patient care. Advances in technology and increased emphasis on patient safety standards drive demand for high-efficiency products and services. The life sciences industry, encompassing research laboratories and biotech companies, necessitates stringent infection control measures to ensure the integrity of research and production processes. The life sciences industry seeks innovative sterilization and decontamination technologies that seamlessly integrate into their operations. The focus is on effective solutions without compromising sensitive materials or experimental outcomes. For medical device companies, infection control is pivotal in medical product design, manufacture, and usage. The demand here is for sterilization processes and coatings that prevent microbial contamination of devices, particularly those involved in invasive procedures. Partnering with infection control specialists who can offer custom solutions tailored to specific device requirements represents a strategic opportunity. Pharmaceutical companies need infection control to ensure the sterility of products and the cleanroom environments in which they are produced. Pharmaceutical companies are interested in technologies and services that maintain aseptic conditions and prevent cross-contamination during manufacturing. As these companies often operate globally, there is a growing demand for compliance with international standards and scalable solutions.

Regional Insights

The Americas have demonstrated high adoption rates of advanced infection control technologies, driven by stringent regulatory guidelines from agencies such as the CDC and FDA. This region is home to several companies in the infection control market, contributing significantly to global production capabilities. Furthermore, there is a strong focus on research and innovation, enabling continuous advancements in infection control methods. Conversely, the APAC region is witnessing the fastest growth in this sector, attributed to rising awareness of health and hygiene practices, increasing healthcare expenditures, and expanding healthcare infrastructure, especially in countries such as China and India. The production landscape here is marked by a mix of local and international companies, with efforts to expand manufacturing capabilities to meet the growing demand. The EMEA region presents a diverse picture, with well-established infection control practices in European countries driven by healthcare regulations and high-quality standards. The Middle East and Africa, while gradually improving, face challenges related to uneven access to healthcare facilities and technologies. This region hosts a blend of domestic and international companies focusing on expanding their reach to underserved areas, underscoring the potential for growth in infection control practices.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Infection Control Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Infection Control Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AliMed, Inc., Amway Corporation, Ansell Ltd., ASP International GmbH, Becton, Dickinson and Company, Belimed AG, bioMerieux SA, Cantel Medical Group, Cardinal Health Inc., Codi Group BV, Colgate-Palmolive Company, Dandong Huayang Textile and Garment Co., Ltd., Diversey Holdings Ltd., Ecolab Corporation, Embuer Health Pvt. Ltd., Essity AB, F. Hoffmann-La Roche Ltd., Getinge AB, Go Green Solutions, LLC, GOJO Industries, Inc., Hartmann Group, Jiaxing Hongjie Commodity Co., Ltd., Kao Corporation, Kimberly-Clark Corporation, Matachana Group, Medexter Healthcare GmbH, Medline Industries, LP, MELAG Medizintechnik GmbH & Co. KG, Merck KGaA, Metrex Research, LLC, Nice-Pak Products, Inc., Olympus Corporation, Pal International Ltd., Pfizer Inc., Procter & Gamble Company, Professional Disposables International, Inc., Reckitt Benckiser Group PLC, Rockline Industries Ltd., S. C. Johnson & Son, Inc., Sotera Health LLC, Sterigenics International LLC, Steris Corporation, Unicharm Corporation, Unilever PLC, Weiman Products, LLC, World Precision Instruments, LLC, and Yessor Wipes.

Market Segmentation & Coverage

This research report categorizes the Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Transmission
  • Airborne
  • Bloodborne
  • Contract

• Products
  • Cleaning & Disinfection
    • Disinfectants
      • Hand Disinfectants
      • Instrument Disinfectants
      • Skin Disinfectants
      • Surface Disinfectants

• Equipment
  • Flusher Disinfectors
  • Ultrasonic Cleaners
  • UV-Ray Disinfectors
  • Washer Disinfectors

• Formulation
  • Disinfectant Sprays
  • Disinfectant Wipes
  • Liquid Disinfectants

• Level of Disinfection
  • High-Level
  • Intermediate-Level
  • Low-Level
• Endoscope Reprocessing
  • Consumables
  • Equipment

• Protective Barriers
  • Covers & Closures
  • Goggles
  • Medical Nonwovens

• Sterilization
  • E-Beam Sterilization
  • Equipment Sterilization
  • ETO Sterilization
  • Filtration Sterilization
  • Gamma Sterilization
  • Radiation Sterilization
  • Steam Sterilization
• End-User
  • Food & Beverage Companies
  • Hospitals & Clinics
  • Life Sciences Industry
  • Medical Device Companies
  • Pharmaceutical Companies

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Infection Control Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Infection Control Market?

3. What are the technology trends and regulatory frameworks in the Infection Control Market?

4. What is the market share of the leading vendors in the Infection Control Market?

5. Which modes and strategic moves are suitable for entering the Infection Control Market?

[195 Pages Report] The Infection Control Market size was estimated at USD 43.62 billion in 2023 and expected to reach USD 45.79 billion in 2024, at a CAGR 5.23% to reach USD 62.36 billion by 2030.

Infection control refers to the disciplined approach and practices designed to prevent the spreading of infectious diseases. This multifaceted discipline encompasses identifying sources of infections, understanding the mechanisms through which infections spread, and implementing strategic measures to mitigate the transmission of infectious agents. It involves a combination of science, theory, and practices to protect healthcare providers, patients, and the public from the dangers of contagious diseases. The infection control market is experiencing robust growth, driven by the rise of hospital-acquired infection incidence, heightened awareness and demand for infection control amidst infectious disease outbreaks, advancements in sterilization technologies, expanding healthcare infrastructure, and stringent global regulations on infection prevention practices. Opportunities for market expansion include the development of eco-friendly disinfection methods, implementation of IoT and AI for hygiene management, entry into emerging markets with rising healthcare standards, and innovative solutions for the disposal of infectious waste. Nonetheless, challenges such as the high costs of advanced sterilization equipment, limited awareness and practice adoption in lower-income regions, healthcare worker resistance due to training deficiencies, and environmental concerns over infectious waste disposal are notable barriers. To achieve sustained growth, the sector is poised for innovation in cost-effective sterilization technologies, eco-friendly disposable products, automated and real-time infection control monitoring, and collaborative efforts to make infection control solutions more accessible and affordable worldwide.

Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices

Cleaning & disinfection are essential in preventing the spread of infection, this category includes products designed to eliminate or reduce harmful pathogens on surfaces, instruments, and skin. Hand Disinfectants are formulated to kill or inhibit the growth of germs on human hands. These are crucial in healthcare settings to prevent cross-contamination and infections. Instrument disinfectants are used for sterilizing and disinfecting medical instruments, reducing the risk of infection transmission. Skin disinfectants are antiseptic agents used to cleanse the skin of microbes before medical procedures or after exposure to contaminants. Surface disinfectants are products designed to sanitize surfaces in various environments, effectively reducing the risk of spreading infections. Devices and machines used in the disinfection process enhance efficiency and effectiveness. Flusher disinfectors are automated systems for the cleaning and Disinfection of medical devices and plumbing fixtures to prevent microbial contamination. Ultrasonic cleaners use ultrasonic waves in a cleaning solution to remove contaminants from items, which is particularly effective for delicate instruments. UV-Ray disinfectors that deploy UV-C light to destroy bacterial, viral, and fungal pathogens suitable for surface, water, and air disinfection. Washer disinfectors thoroughly clean and disinfect medical utensils, operating effectively at high temperatures. The physical composition of disinfection agents is tailored for various uses and preferences. Disinfectant sprays are liquid formulations designed for easy application on surfaces or air, offering quick and convenient Disinfection. Disinfectant wipes are pre-moistened towelettes impregnated with disinfectant solutions, ideal for quick cleanup and Disinfection of surfaces. Liquid disinfectants can be applied directly or diluted used for a broad range of disinfection tasks. Disinfection practices are categorized by the extent of microbicidal activity, which is important in selecting the appropriate products for various applications. High-Level Disinfection destroys all microorganisms, except large numbers of bacterial spores. Used for items that come in contact with sterile body areas. Intermediate-level inactivates viruses, bacteria, fungi, and mycobacteria, but not necessarily high numbers of bacterial spores. Low-level eliminates most bacteria, some viruses, and fungi but does not kill mycobacteria or spores and is suitable for non-critical surfaces. Endoscope reprocessing is critical for preventing infections associated with endoscope use, involving specific steps and products to ensure thorough Disinfection. Consumables include detergents, wipes, and brushes specifically designed for cleaning and disinfecting endoscopes. Protective Barriers are quipment and materials that provide a physical barrier, protecting healthcare workers and patients from infectious agents. Covers & closures are designed to seal or cover equipment and areas to prevent contamination. Goggles protect eyes from splashes, sprays, and droplets that may contain infectious agents. Medical nonwovens are disposable fabrics used in medical settings to prevent cross-contamination, including gowns, drapes, and masks. Sterilization is the process that eliminates all forms of microbial life, including spores, employed in healthcare facilities to ensure the safety of medical devices. E-Beam sterilization utilizes electron beams to sterilize medical products quickly and effectively, suitable for various materials. Equipment sterilization involves methods such as steam, dry heat, and chemicals to sterilize medical equipment, ensuring its safe reuse. ETO sterilization uses ethylene oxide gas to sterilize medical devices, effective for materials sensitive to heat and moisture. Filtration sterilization employs physical removal of microorganisms through a filtration membrane, suitable for heat-sensitive liquids. Gamma sterilization relies on gamma rays to penetrate and sterilize products thoroughly, commonly used for single-use medical devices. Radiation sterilization encompasses gamma and e-beam sterilization, offering deep penetration for various products. Steam sterilization is a widely used, effective method utilizing pressurized steam to achieve microbial inactivation, ideal for heat-resistant devices.

End-User: Evolving usage of infection control in hospitals & clinics sector

In the food and beverage sector, infection control prevents foodborne illnesses through stringent hygiene and sanitization practices. This market segment demands effective solutions against a broad spectrum of pathogens yet safe for use in food processing environments. Growth opportunities lie in innovative disinfection technologies and eco-friendly sanitizers that meet regulatory standards for food safety. Hospitals and clinics remain at the forefront of infection control due to the critical need to prevent healthcare-associated infections (HAIs). Hospitals and clinics require comprehensive solutions, including sterilization equipment, disinfectants, and services that ensure a sterile environment for patient care. Advances in technology and increased emphasis on patient safety standards drive demand for high-efficiency products and services. The life sciences industry, encompassing research laboratories and biotech companies, necessitates stringent infection control measures to ensure the integrity of research and production processes. The life sciences industry seeks innovative sterilization and decontamination technologies that seamlessly integrate into their operations. The focus is on effective solutions without compromising sensitive materials or experimental outcomes. For medical device companies, infection control is pivotal in medical product design, manufacture, and usage. The demand here is for sterilization processes and coatings that prevent microbial contamination of devices, particularly those involved in invasive procedures. Partnering with infection control specialists who can offer custom solutions tailored to specific device requirements represents a strategic opportunity. Pharmaceutical companies need infection control to ensure the sterility of products and the cleanroom environments in which they are produced. Pharmaceutical companies are interested in technologies and services that maintain aseptic conditions and prevent cross-contamination during manufacturing. As these companies often operate globally, there is a growing demand for compliance with international standards and scalable solutions.

Regional Insights

The Americas have demonstrated high adoption rates of advanced infection control technologies, driven by stringent regulatory guidelines from agencies such as the CDC and FDA. This region is home to several companies in the infection control market, contributing significantly to global production capabilities. Furthermore, there is a strong focus on research and innovation, enabling continuous advancements in infection control methods. Conversely, the APAC region is witnessing the fastest growth in this sector, attributed to rising awareness of health and hygiene practices, increasing healthcare expenditures, and expanding healthcare infrastructure, especially in countries such as China and India. The production landscape here is marked by a mix of local and international companies, with efforts to expand manufacturing capabilities to meet the growing demand. The EMEA region presents a diverse picture, with well-established infection control practices in European countries driven by healthcare regulations and high-quality standards. The Middle East and Africa, while gradually improving, face challenges related to uneven access to healthcare facilities and technologies. This region hosts a blend of domestic and international companies focusing on expanding their reach to underserved areas, underscoring the potential for growth in infection control practices.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Infection Control Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Infection Control Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AliMed, Inc., Amway Corporation, Ansell Ltd., ASP International GmbH, Becton, Dickinson and Company, Belimed AG, bioMerieux SA, Cantel Medical Group, Cardinal Health Inc., Codi Group BV, Colgate-Palmolive Company, Dandong Huayang Textile and Garment Co., Ltd., Diversey Holdings Ltd., Ecolab Corporation, Embuer Health Pvt. Ltd., Essity AB, F. Hoffmann-La Roche Ltd., Getinge AB, Go Green Solutions, LLC, GOJO Industries, Inc., Hartmann Group, Jiaxing Hongjie Commodity Co., Ltd., Kao Corporation, Kimberly-Clark Corporation, Matachana Group, Medexter Healthcare GmbH, Medline Industries, LP, MELAG Medizintechnik GmbH & Co. KG, Merck KGaA, Metrex Research, LLC, Nice-Pak Products, Inc., Olympus Corporation, Pal International Ltd., Pfizer Inc., Procter & Gamble Company, Professional Disposables International, Inc., Reckitt Benckiser Group PLC, Rockline Industries Ltd., S. C. Johnson & Son, Inc., Sotera Health LLC, Sterigenics International LLC, Steris Corporation, Unicharm Corporation, Unilever PLC, Weiman Products, LLC, World Precision Instruments, LLC, and Yessor Wipes.

Market Segmentation & Coverage

This research report categorizes the Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Transmission
  • Airborne
  • Bloodborne
  • Contract

• Products
  • Cleaning & Disinfection
    • Disinfectants
      • Hand Disinfectants
      • Instrument Disinfectants
      • Skin Disinfectants
      • Surface Disinfectants

• Equipment
  • Flusher Disinfectors
  • Ultrasonic Cleaners
  • UV-Ray Disinfectors
  • Washer Disinfectors

• Formulation
  • Disinfectant Sprays
  • Disinfectant Wipes
  • Liquid Disinfectants

• Level of Disinfection
  • High-Level
  • Intermediate-Level
  • Low-Level
• Endoscope Reprocessing
  • Consumables
  • Equipment

• Protective Barriers
  • Covers & Closures
  • Goggles
  • Medical Nonwovens

• Sterilization
  • E-Beam Sterilization
  • Equipment Sterilization
  • ETO Sterilization
  • Filtration Sterilization
  • Gamma Sterilization
  • Radiation Sterilization
  • Steam Sterilization
• End-User
  • Food & Beverage Companies
  • Hospitals & Clinics
  • Life Sciences Industry
  • Medical Device Companies
  • Pharmaceutical Companies

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Infection Control Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Infection Control Market?

3. What are the technology trends and regulatory frameworks in the Infection Control Market?

4. What is the market share of the leading vendors in the Infection Control Market?

5. Which modes and strategic moves are suitable for entering the Infection Control Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of hospital-acquired infections and surging usage of infection control products
    • 5.1.1.2. Increasing number of surgical procedures and need for appropriate safety methods
    • 5.1.1.3. Upsurging adoption of infection control products in medical device and pharmaceutical industry
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse effects associated with chemical based disinfectants
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing outsourcing of sterilization services by hospitals, and clinics
    • 5.1.3.2. Growing investments by manufacturers in the production of infection control products
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of substitute products and techniques for infection control
• 5.2. Market Segmentation Analysis
  • 5.2.1. Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices
  • 5.2.2. End-User: Evolving usage of infection control in hospitals & clinics sector
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Infection Control Market, by Transmission

• 6.1. Introduction
• 6.2. Airborne
• 6.3. Bloodborne
• 6.4. Contract

7. Infection Control Market, by Products

• 7.1. Introduction
• 7.2. Cleaning & Disinfection
• 7.3. Endoscope Reprocessing
• 7.4. Protective Barriers
• 7.5. Sterilization

8. Infection Control Market, by End-User

• 8.1. Introduction
• 8.2. Food & Beverage Companies
• 8.3. Hospitals & Clinics
• 8.4. Life Sciences Industry
• 8.5. Medical Device Companies
• 8.6. Pharmaceutical Companies

9. Americas Infection Control Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Infection Control Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Infection Control Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Freudenberg Medical Establishes Second Production Facility In Costa Rica
  • 12.3.2. WPT Nonwovens Invests USD 19.5M in Kentucky Manufacturing Facility, Boosting Local Economy
  • 12.3.3. Berry Launches Lightweight Tube Closure Solution Catering To The Stringent Safety And Hygiene Standards Mandated In Infection Control Protocols
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio